Zobrazeno 1 - 10
of 38
pro vyhledávání: '"I, Sinapi"'
Autor:
R. Saúde-Conde, T. Vandamme, M. De Backer, P. Martinive, A. Covas, A. Deleporte, A. Dermine, F. Forget, K. Geboes, Q. Gilliaux, Y. Gokburun, E. Gonne, I. Joye, S. Lecomte, G. Liberale, W. Lybaert, L. Moretti, L. Mortier, S. Mupingu Mwanawa, F. Puleo, E.D. Saad, I. Sinapi, L. Annemans, M. Buyse, F. Sclafani
Publikováno v:
ESMO Gastrointestinal Oncology, Vol 4, Iss , Pp 100067- (2024)
Although total neoadjuvant therapy (TNT) is a new standard of care for locally advanced rectal cancer (LARC), there are no data to confirm the safety and efficacy of this approach in older patients. SHAPERS is a multicentre, open-label, randomised pr
Externí odkaz:
https://doaj.org/article/fba73f9b97c443b8bbc3ea74a8d54b96
Autor:
C. van Marcke, N. Honoré, A. van der Elst, S. Beyaert, F. Derouane, C. Dumont, F. Aboubakar Nana, J. F. Baurain, I. Borbath, P. Collard, F. Cornélis, A. De Cuyper, F. P. Duhoux, B. Filleul, R. Galot, M. Gizzi, F. Mazzeo, T. Pieters, E. Seront, I. Sinapi, M. Van den Eynde, N. Whenham, J. C. Yombi, A. Scohy, A. van Maanen, J. P. Machiels
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background The viral pandemic coronavirus disease 2019 (COVID-19) has disrupted cancer patient management around the world. Most reported data relate to incidence, risk factors, and outcome of severe COVID-19. The safety of systemic anti-can
Externí odkaz:
https://doaj.org/article/95bcb44e832f4789979432b41c90aaa4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Emmanuel Seront, M. Van den Eynde, Thierry Pieters, Anaïs Scohy, Philippe Collard, C. Dumont, F. Aboubakar Nana, A. van der Elst, R. Galot, Jean Cyr Yombi, Frank Cornelis, Simon Beyaert, Marco Gizzi, Ivan Borbath, F. Derouane, A. van Maanen, Filomena Mazzeo, N. Whenham, N. Honoré, François Duhoux, A. De Cuyper, Jean-François Baurain, Bertrand Filleul, I. Sinapi, J.-P. Machiels, C. van Marcke
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
BMC cancer, Vol. 21, no.1, p. 578 [1-12] (2021)
BMC Cancer
BMC cancer, Vol. 21, no.1, p. 578 [1-12] (2021)
BackgroundThe viral pandemic coronavirus disease 2019 (COVID-19) has disrupted cancer patient management around the world. Most reported data relate to incidence, risk factors, and outcome of severe COVID-19. The safety of systemic anti-cancer therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b52246cc3435a528b1aacdaf46d72ecf
https://doaj.org/article/95bcb44e832f4789979432b41c90aaa4
https://doaj.org/article/95bcb44e832f4789979432b41c90aaa4
Autor:
C. Van Marcke, N. Honoré, A. Van Der Elst, S. Beyaert, F. Derouane, C. Dumont, F. Aboubakar Nana, J. F. Baurain, I. Borbath, P. Collard, F. Cornélis, A. De Cuyper, F. P. Duhoux, B. Filleul, R. Galot, M. Gizzi, F. Mazzeo, T. Pieters, E. Seront, I. Sinapi, M. Van Den Eynde, N. Whenham, J. C. Yombi, A. Scohy, A. Van Maanen, J. P. Machiels
Additional file 1: Table S1. Characteristics of patients who had SARS-CoV-2 RT-PCR. Table S2. Characteristics of patients diagnosed by SARS-CoV-2 serology (SARS-CoV-2 RT-PCR not performed or negative). Table S3. Adverse events with systemic therapy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20714542e956f6b25b5470f879175dcf
Autor:
Bertrand Filleul, N. Whenham, Frank Aboubakar Nana, Philippe Collard, Athénaïs van der Elst, Marco Gizzi, Marc Van den Eynde, Cédric van Marcke, Rachel Galot, Jean Cyr Yombi, Jean-François Baurain, Aline Van Maanen, François Duhoux, Emmanuel Seront, N. Honoré, Jean-Pascal Machiels, Caroline Dumont, I. Sinapi, Simon Beyaert, Françoise Derouane, Thierry Pieters, Anaïs Scohy, Ivan Borbath, Filomena Mazzeo, Astrid De Cuyper, Frank Cornelis
Background The viral pandemic coronavirus disease 2019 (COVID-19) has disrupted cancer patient management around the world. Most reported data relate to incidence, risk factors, and outcome of severe COVID-19. The safety of systemic anti-cancer thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dc34d76771e1dfb437bc000a0947656
https://doi.org/10.21203/rs.3.rs-102553/v1
https://doi.org/10.21203/rs.3.rs-102553/v1
Autor:
I. Sinapi, J-L. van Laethem, Nicolas Huyghe, Pamela Baldin, A. Hendlisz, Thierry Delaunoit, S. Delmarcelle, I. Bar, A. De Cuyper, Javier Carrasco, G. Van Ooteghem, G. Beniuga, David Schröder, J-C. Coche, M. Van den Eynde, A-S. Boulanger, Karin Haustermans
Publikováno v:
Annals of Oncology, Vol. 32, no.5, p. S537 (2021)
Background Radiotherapy association with immunotherapy has a strong rationale. This study evaluates this combination before surgery in locally advanced rectal cancer (RC). Methods R-IMMUNE (NCT03127007), a multicentric phase Ib/II prospective trial i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2515302c78b9447e54929a6efa64c544
https://doi.org/10.1016/j.annonc.2021.08.919
https://doi.org/10.1016/j.annonc.2021.08.919
Autor:
Anne Jouret-Mourin, M-L. Castella, A. van Maanen, G. Beniuga, S. Roland, Pamela Baldin, N. Bletard, Javier Carrasco, Philippe Vergauwe, L. D'Hondt, B. Massart, Gauthier Demolin, M. Mailleux, M. Van den Eynde, A. De Cuyper, D. Vandaele, I. Sinapi, Monique Delos
Publikováno v:
Annals of Oncology, Vol. 31, no.4, p. S433 (2020)
Background Pathological response (PR) of resected CRCM after preop treatment is a recognized prognostic factor. Retrospective studies reported that BEV + oxaliplatin-based chemotherapy increased PR compared to irinotecan-based chemotherapy. In this t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c55972f3045809b463d233129a408894
https://doi.org/10.1016/j.annonc.2020.08.560
https://doi.org/10.1016/j.annonc.2020.08.560
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Medical Case Reports
Journal of Medical Case Reports, Vol. 10, no.1, p. 178 (2016)
Journal of Medical Case Reports, Vol. 10, no.1, p. 178 (2016)
Background Tumor lysis syndrome is a rare and potentially fatal complication of oncologic treatments, especially in solid tumors. To the best of our knowledge, tumor lysis syndrome has never been reported after trastuzumab and pertuzumab combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::386904e2e014e97aa96939314f7392da
http://europepmc.org/articles/PMC4911682
http://europepmc.org/articles/PMC4911682